| regulation of microvillus organization | GO:0032530 | 3 | 0.784 | |
| positive regulation of transforming growth factor beta secretion | GO:2001203 | 1 | 0.700 | |
| regulation of transforming growth factor beta secretion | GO:2001201 | 1 | 0.641 | |
| transforming growth factor beta secretion | GO:0038044 | 1 | 0.603 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.557 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.545 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.437 | |
| circulatory system process | GO:0003013 | 197 | 0.325 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.303 | |
| angiogenesis | GO:0001525 | 201 | 0.263 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.249 | |
| blood circulation | GO:0008015 | 195 | 0.232 | |
| regulation of cell motility | GO:2000145 | 236 | 0.181 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.178 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.178 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.168 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.167 | |
| protein catabolic process | GO:0030163 | 221 | 0.154 | |
| muscle fiber development | GO:0048747 | 76 | 0.140 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.129 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.126 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.121 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.120 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.118 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.116 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.114 | |
| regulation of cell migration | GO:0030334 | 219 | 0.112 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.109 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.109 | |
| regulation of interleukin 10 secretion | GO:2001179 | 4 | 0.107 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.106 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.105 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.105 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.104 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.102 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.101 | |
| muscle cell development | GO:0055001 | 133 | 0.100 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.096 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.095 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.093 | |
| interleukin 10 secretion | GO:0072608 | 4 | 0.093 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.092 | |
| myotube differentiation | GO:0014902 | 105 | 0.092 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.091 | |
| regulation of protein localization | GO:0032880 | 231 | 0.087 | |
| mapk cascade | GO:0000165 | 281 | 0.086 | |
| protein secretion | GO:0009306 | 111 | 0.086 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.086 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.085 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.084 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.083 | |
| protein maturation | GO:0051604 | 176 | 0.083 | |
| inflammatory response | GO:0006954 | 244 | 0.083 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.081 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.080 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.080 | |
| negative regulation of myoblast differentiation | GO:0045662 | 18 | 0.080 | |
| regulation of cell activation | GO:0050865 | 289 | 0.080 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.080 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.079 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.079 | |
| negative regulation of muscle cell differentiation | GO:0051148 | 33 | 0.078 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.077 | |
| stem cell proliferation | GO:0072089 | 117 | 0.075 | |
| muscle tissue development | GO:0060537 | 308 | 0.074 | |
| cellular homeostasis | GO:0019725 | 240 | 0.074 | |
| placenta development | GO:0001890 | 140 | 0.073 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.073 | |
| myotube cell development | GO:0014904 | 60 | 0.072 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.072 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.070 | |
| striated muscle cell development | GO:0055002 | 125 | 0.070 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.070 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.068 | |
| regulation of tube size | GO:0035150 | 57 | 0.067 | |
| epithelial cell development | GO:0002064 | 159 | 0.067 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.066 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.065 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.064 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.063 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.063 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.062 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.061 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.061 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.060 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.060 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.059 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.058 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.058 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.058 | |
| rhythmic process | GO:0048511 | 174 | 0.058 | |
| extracellular structure organization | GO:0043062 | 148 | 0.058 | |
| cytokine production | GO:0001816 | 319 | 0.058 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.056 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.055 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.055 | |
| developmental maturation | GO:0021700 | 193 | 0.054 | |
| neuronal action potential | GO:0019228 | 54 | 0.054 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.054 | |
| regulation of protein transport | GO:0051223 | 163 | 0.054 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.052 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.051 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.051 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.050 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.050 | |
| regulation of eosinophil migration | GO:2000416 | 2 | 0.050 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.050 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.049 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.049 | |
| cd4 positive alpha beta t cell cytokine production | GO:0035743 | 4 | 0.049 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.048 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.048 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.047 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.047 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.047 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.046 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.046 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.044 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.044 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.044 | |
| ovulation cycle | GO:0042698 | 59 | 0.043 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.043 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.043 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.043 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.043 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.042 | |
| cytokine secretion | GO:0050663 | 72 | 0.042 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.042 | |
| b cell differentiation | GO:0030183 | 78 | 0.041 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.041 | |
| regulation of secretion | GO:0051046 | 274 | 0.041 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.041 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.041 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.040 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.039 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.039 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.039 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.039 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.038 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.038 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.038 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.038 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.037 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.037 | |
| mitral valve development | GO:0003174 | 4 | 0.037 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.037 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.037 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.037 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.037 | |
| oxidation reduction process | GO:0055114 | 342 | 0.036 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.036 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.036 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.036 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.036 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.036 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.036 | |
| response to oxygen levels | GO:0070482 | 62 | 0.035 | |
| regulation of system process | GO:0044057 | 200 | 0.035 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.035 | |
| cellular response to lipid | GO:0071396 | 145 | 0.035 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.035 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.035 | |
| myoblast differentiation | GO:0045445 | 52 | 0.034 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.034 | |
| cation transport | GO:0006812 | 399 | 0.034 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.034 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.034 | |
| cell recognition | GO:0008037 | 83 | 0.034 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.033 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.033 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.033 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.033 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.033 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.033 | |
| cellular response to gonadotropin stimulus | GO:0071371 | 4 | 0.033 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.033 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.032 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.032 | |
| protein processing | GO:0016485 | 163 | 0.032 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.032 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.032 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.032 | |
| compound eye development | GO:0048749 | 1 | 0.031 | |
| tendon formation | GO:0035992 | 4 | 0.031 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.031 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.031 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.030 | |
| adaptive immune response | GO:0002250 | 155 | 0.030 | |
| blood coagulation | GO:0007596 | 76 | 0.030 | |
| camera type eye development | GO:0043010 | 266 | 0.030 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.030 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.030 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.029 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.029 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.029 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.028 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.028 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.028 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.028 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.028 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.027 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.027 | |
| stem cell differentiation | GO:0048863 | 268 | 0.027 | |
| midgut development | GO:0007494 | 4 | 0.027 | |
| calcium ion transport | GO:0006816 | 159 | 0.027 | |
| regulation of neuroblast proliferation | GO:1902692 | 27 | 0.027 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.027 | |
| camp metabolic process | GO:0046058 | 40 | 0.027 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.026 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.026 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.026 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.026 | |
| immune effector process | GO:0002252 | 321 | 0.026 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.026 | |
| regulation of monocyte chemotaxis | GO:0090025 | 3 | 0.026 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.026 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.026 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.025 | |
| negative regulation of epithelial cell migration | GO:0010633 | 9 | 0.025 | |
| positive regulation of endothelial cell migration | GO:0010595 | 12 | 0.025 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.025 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 26 | 0.025 | |
| b cell activation | GO:0042113 | 161 | 0.025 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.025 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.025 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.025 | |
| endocrine process | GO:0050886 | 39 | 0.024 | |
| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.024 | |
| response to oxidative stress | GO:0006979 | 123 | 0.024 | |
| circadian rhythm | GO:0007623 | 114 | 0.024 | |
| sclerotome development | GO:0061056 | 4 | 0.024 | |
| mitochondrion organization | GO:0007005 | 134 | 0.024 | |
| endothelial cell migration | GO:0043542 | 44 | 0.024 | |
| wound healing | GO:0042060 | 157 | 0.023 | |
| regulation of exit from mitosis | GO:0007096 | 1 | 0.023 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.023 | |
| peptide secretion | GO:0002790 | 114 | 0.023 | |
| sensory perception | GO:0007600 | 245 | 0.023 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.023 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.023 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.023 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.023 | |
| embryonic placenta development | GO:0001892 | 98 | 0.023 | |
| regulation of ossification | GO:0030278 | 112 | 0.023 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.023 | |
| negative regulation of synapse maturation | GO:2000297 | 2 | 0.023 | |
| multicellular organism growth | GO:0035264 | 161 | 0.023 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.023 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.023 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.022 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.022 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.022 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.022 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.022 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.022 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.022 | |
| maintenance of location | GO:0051235 | 89 | 0.022 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.022 | |
| coagulation | GO:0050817 | 78 | 0.021 | |
| chemotaxis | GO:0006935 | 247 | 0.021 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.021 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.021 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.021 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 42 | 0.021 | |
| connective tissue development | GO:0061448 | 179 | 0.021 | |
| regulation of blood vessel endothelial cell migration | GO:0043535 | 12 | 0.021 | |
| amide transport | GO:0042886 | 138 | 0.021 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.021 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.021 | |
| intracellular protein transport | GO:0006886 | 204 | 0.021 | |
| protein targeting | GO:0006605 | 143 | 0.021 | |
| lateral line system development | GO:0048925 | 1 | 0.021 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.021 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.021 | |
| regulation of ion transport | GO:0043269 | 215 | 0.020 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.020 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.020 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.020 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.020 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.020 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.020 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.020 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.020 | |
| regulation of camp biosynthetic process | GO:0030817 | 25 | 0.020 | |
| ossification | GO:0001503 | 216 | 0.020 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.020 | |
| cation homeostasis | GO:0055080 | 212 | 0.020 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.020 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.019 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.019 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.019 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.019 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.019 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.019 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.019 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.019 | |
| skeletal system development | GO:0001501 | 356 | 0.019 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.019 | |
| trophoblast giant cell differentiation | GO:0060707 | 15 | 0.019 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.019 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.019 | |
| retinal cone cell development | GO:0046549 | 8 | 0.019 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.019 | |
| regeneration | GO:0031099 | 38 | 0.019 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.019 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.019 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.019 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.019 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.018 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.018 | |
| cell maturation | GO:0048469 | 127 | 0.018 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.018 | |
| fertilization | GO:0009566 | 127 | 0.018 | |
| locomotory behavior | GO:0007626 | 195 | 0.018 | |
| positive regulation of neuroblast proliferation | GO:0002052 | 19 | 0.018 | |
| genetic imprinting | GO:0071514 | 27 | 0.018 | |
| positive regulation of inner ear receptor cell differentiation | GO:2000982 | 1 | 0.018 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.018 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.018 | |
| negative regulation of interleukin 13 production | GO:0032696 | 2 | 0.018 | |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.018 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.018 | |
| urogenital system development | GO:0001655 | 261 | 0.018 | |
| semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:0071527 | 1 | 0.018 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.018 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.018 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.018 | |
| tissue remodeling | GO:0048771 | 102 | 0.018 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.018 | |
| negative regulation of oxidative phosphorylation uncoupler activity | GO:2000276 | 2 | 0.018 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.018 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.018 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.018 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.018 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.018 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.017 | |
| organelle fission | GO:0048285 | 170 | 0.017 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.017 | |
| heart morphogenesis | GO:0003007 | 178 | 0.017 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.017 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.017 | |
| regulation of binding | GO:0051098 | 111 | 0.017 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.017 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.017 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.017 | |
| regulation of monocyte extravasation | GO:2000437 | 2 | 0.017 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.017 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.017 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.017 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.017 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.017 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.017 | |
| regulation of interleukin 13 secretion | GO:2000665 | 2 | 0.016 | |
| visual perception | GO:0007601 | 52 | 0.016 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.016 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.016 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.016 | |
| peptide metabolic process | GO:0006518 | 46 | 0.016 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.016 | |
| detection of abiotic stimulus | GO:0009582 | 60 | 0.016 | |
| response to peptide hormone | GO:0043434 | 127 | 0.016 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.016 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.016 | |
| olfactory learning | GO:0008355 | 2 | 0.016 | |
| stem cell development | GO:0048864 | 219 | 0.016 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.016 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.016 | |
| epithelium migration | GO:0090132 | 63 | 0.016 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.016 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.016 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.016 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.016 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.016 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.016 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.015 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.015 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.015 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.015 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.015 | |
| heart contraction | GO:0060047 | 93 | 0.015 | |
| skin development | GO:0043588 | 220 | 0.015 | |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.015 | |
| detection of stimulus | GO:0051606 | 84 | 0.015 | |
| regulation of protein processing | GO:0070613 | 96 | 0.015 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.015 | |
| c21 steroid hormone biosynthetic process | GO:0006700 | 3 | 0.015 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.015 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.015 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.015 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.015 | |
| regulation of intestinal epithelial structure maintenance | GO:0060730 | 1 | 0.015 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.015 | |
| protein ubiquitination | GO:0016567 | 171 | 0.015 | |
| fat soluble vitamin catabolic process | GO:0042363 | 1 | 0.015 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.015 | |
| positive regulation of epithelial cell migration | GO:0010634 | 19 | 0.015 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.015 | |
| relaxation of muscle | GO:0090075 | 18 | 0.015 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.015 | |
| protein localization to organelle | GO:0033365 | 185 | 0.015 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.015 | |
| negative regulation of growth | GO:0045926 | 99 | 0.014 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.014 | |
| heart process | GO:0003015 | 94 | 0.014 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.014 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.014 | |
| interleukin 5 secretion | GO:0072603 | 2 | 0.014 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.014 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.014 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.014 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.014 | |
| positive regulation of semaphorin plexin signaling pathway | GO:2001262 | 1 | 0.014 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.014 | |
| fat cell differentiation | GO:0045444 | 160 | 0.014 | |
| regulation of action potential | GO:0098900 | 4 | 0.014 | |
| tissue migration | GO:0090130 | 68 | 0.014 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.014 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 1 | 0.014 | |
| digestive tract development | GO:0048565 | 190 | 0.014 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.014 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.014 | |
| lipid localization | GO:0010876 | 126 | 0.014 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.014 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.014 | |
| collagen fibril organization | GO:0030199 | 32 | 0.014 | |
| spermatid development | GO:0007286 | 108 | 0.014 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.014 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.014 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.013 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.013 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.013 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.013 | |
| insulin secretion | GO:0030073 | 89 | 0.013 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.013 | |
| transmembrane transport | GO:0055085 | 412 | 0.013 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.013 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.013 | |
| germ cell development | GO:0007281 | 185 | 0.013 | |
| auditory receptor cell differentiation | GO:0042491 | 37 | 0.013 | |
| regulation of endothelial cell migration | GO:0010594 | 22 | 0.013 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.013 | |
| response to inorganic substance | GO:0010035 | 96 | 0.013 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.013 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.013 | |
| sodium ion transport | GO:0006814 | 73 | 0.013 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.013 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.013 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.013 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.013 | |
| bone morphogenesis | GO:0060349 | 78 | 0.013 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.013 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.013 | |
| extracellular matrix dependent thymocyte migration | GO:0072680 | 1 | 0.013 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.013 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.013 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.013 | |
| anion transport | GO:0006820 | 177 | 0.013 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.013 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.013 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.013 | |
| negative regulation of peroxisome proliferator activated receptor signaling pathway | GO:0035359 | 3 | 0.013 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.013 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.013 | |
| tube formation | GO:0035148 | 140 | 0.013 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.013 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.013 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.013 | |
| neural tube development | GO:0021915 | 160 | 0.013 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.013 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.013 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.013 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.012 | |
| neural retina development | GO:0003407 | 41 | 0.012 | |
| response to radiation | GO:0009314 | 165 | 0.012 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.012 | |
| establishment or maintenance of bipolar cell polarity | GO:0061245 | 21 | 0.012 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.012 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.012 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.012 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.012 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.012 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.012 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.012 | |
| regulation of interleukin 5 secretion | GO:2000662 | 2 | 0.012 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.012 | |
| tissue homeostasis | GO:0001894 | 115 | 0.012 | |
| cell adhesion | GO:0007155 | 329 | 0.012 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.012 | |
| hormone metabolic process | GO:0042445 | 86 | 0.012 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.012 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.012 | |
| bone development | GO:0060348 | 120 | 0.012 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.012 | |
| t cell differentiation | GO:0030217 | 174 | 0.012 | |
